These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10491731)

  • 1. Concluding remarks. Pursuit of the optimal outcome in hypertension.
    Hansson L
    Clin Pharmacokinet; 1999; 37 Suppl 1():33-8. PubMed ID: 10491731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R
    Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the pharmacology and clinical efficacy of indapamide sustained release.
    Sassard J; Bataillard A; McIntyre H
    Fundam Clin Pharmacol; 2005 Dec; 19(6):637-45. PubMed ID: 16313275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indapamide sustained release: a review of its use in the treatment of hypertension.
    Robinson DM; Wellington K
    Drugs; 2006; 66(2):257-71. PubMed ID: 16451099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of Natrilix SR in the treatment of at-risk hypertensive patients.
    Ambrosioni E; Veronesi M
    J Hypertens Suppl; 2003 Mar; 21(1):S13-7. PubMed ID: 12769162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renaissance of diuretics in the treatment of hypertension].
    Hörl WH
    Wien Klin Wochenschr; 1999 Nov; 111(21):903-7. PubMed ID: 10599155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delapril plus indapamide: a review of the combination in the treatment of hypertension.
    Cavalieri L; Cremonesi G
    Clin Drug Investig; 2007; 27(6):367-80. PubMed ID: 17506588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.
    Waeber B; Rotaru C; Feihl F
    Expert Opin Pharmacother; 2012 Jul; 13(10):1515-26. PubMed ID: 22725706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results].
    Guez D; Mallion JM; Degaute JP; Malini PL; Baldwin R; Rodriguez-Pujol D; de Cordoüe A; Barrandon S; Chastang C; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():17-25. PubMed ID: 8952810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination.
    McClellan KJ; Markham A
    Drugs; 1999 Aug; 58(2):297-302; discussion 303-4. PubMed ID: 10473021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
    Asmar R
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia of diuretic therapy.
    Ames R
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes.
    Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC
    Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.
    Weidmann P
    Drug Saf; 2001; 24(15):1155-65. PubMed ID: 11772148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E
    Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.